153 related articles for article (PubMed ID: 37316369)
1. Machine Learning-Based Development of Nomogram for Hepatocellular Carcinoma to Predict Acute Liver Function Deterioration After Drug-Eluting Beads Transarterial Chemoembolization.
Li J; Zhang Y; Ye H; Hu L; Li X; Li Y; Yu P; Wu B; Lv P; Li Z
Acad Radiol; 2023 Sep; 30 Suppl 1():S40-S52. PubMed ID: 37316369
[TBL] [Abstract][Full Text] [Related]
2. CT-based radiomics nomogram for prediction of survival after transarterial chemoembolization with drug-eluting beads in patients with hepatocellular carcinoma and portal vein tumor thrombus.
Cheng S; Hu G; Jin Z; Wang Z; Xue H
Eur Radiol; 2023 Dec; 33(12):8715-8726. PubMed ID: 37436507
[TBL] [Abstract][Full Text] [Related]
3. Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma.
Niu XK; He XF
World J Gastroenterol; 2021 Jan; 27(2):189-207. PubMed ID: 33510559
[TBL] [Abstract][Full Text] [Related]
4. Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE.
Kong C; Zhao Z; Chen W; Lv X; Shu G; Ye M; Song J; Ying X; Weng Q; Weng W; Fang S; Chen M; Tu J; Ji J
Eur Radiol; 2021 Oct; 31(10):7500-7511. PubMed ID: 33860832
[TBL] [Abstract][Full Text] [Related]
5. Preoperative Nomogram Incorporating Clinical Factors, Serological Markers and LI-RADS MRI Features to Predict Early Recurrence of Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
Sheng Y; Wang Q; Liu HF; Chen WH; He ZM; Wang Q
Acad Radiol; 2023 Jul; 30(7):1288-1297. PubMed ID: 36424310
[TBL] [Abstract][Full Text] [Related]
6. A multi-institutional study to predict the benefits of DEB-TACE and molecular targeted agent sequential therapy in unresectable hepatocellular carcinoma using a radiological-clinical nomogram.
Liu K; Zheng X; Lu D; Tan Y; Hou C; Dai J; Shi W; Jiang B; Yao Y; Lu Y; Cao Q; Chen R; Zhang W; Xie J; Chen L; Jiang M; Zhang Z; Liu L; Liu J; Li J; Lv W; Wu X
Radiol Med; 2024 Jan; 129(1):14-28. PubMed ID: 37863847
[TBL] [Abstract][Full Text] [Related]
7. Development of a Prognostic Nomogram in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus Following Trans-Arterial Chemoembolization with Drug-Eluting Beads.
Cheng S; Yu X; Liu S; Jin Z; Xue H; Wang Z; Xie P
Cancer Manag Res; 2021; 13():9367-9377. PubMed ID: 34992462
[TBL] [Abstract][Full Text] [Related]
8. Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study.
He CB; Lao XM; Lin XJ
Chin J Cancer; 2017 Jul; 36(1):59. PubMed ID: 28728568
[TBL] [Abstract][Full Text] [Related]
9. Tumor Response and Nomogram-Based Prognostic Stratification for Hepatocellular Carcinoma After Drug-Eluting Beads Transarterial Chemoembolization.
Ji K; Zhu H; Wu W; Li X; Zhan P; Shi Y; Sun J; Li Z
J Hepatocell Carcinoma; 2022; 9():537-551. PubMed ID: 35698645
[TBL] [Abstract][Full Text] [Related]
10. Prognostic nomogram for hepatocellular carcinoma patients after transarterial chemoembolization based on des-γ-carboxy prothrombin reactivity and modified Response Evaluation Criteria in Solid Tumors.
Zhao SM; Qiu LW; Zhao H; Gu WW; Yang XH; Gu ZX; Shi RF; Ni CF
J Cancer Res Ther; 2021 Jul; 17(3):707-714. PubMed ID: 34269303
[TBL] [Abstract][Full Text] [Related]
11. Prediction of bile duct injury after transarterial chemoembolization for hepatocellular carcinoma: Model establishment and verification.
Guo J; Zhang X; Kong J
Front Oncol; 2022; 12():973045. PubMed ID: 36591492
[TBL] [Abstract][Full Text] [Related]
12. Prognostic nomogram for post-surgical treatment with adjuvant TACE in hepatitis B virus-related hepatocellular carcinoma.
Hu H; Han XK; Long XR; Fan J; Yan ZP; Wang JH; Liu R
Oncotarget; 2016 Sep; 7(36):58302-58314. PubMed ID: 27506942
[TBL] [Abstract][Full Text] [Related]
13. A nomogram to predict survival of patients with intermediate-stage hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation.
Ni JY; Fang ZT; Sun HL; An C; Huang ZM; Zhang TQ; Jiang XY; Chen YT; Xu LF; Huang JH
Eur Radiol; 2020 Apr; 30(4):2377-2390. PubMed ID: 31900694
[TBL] [Abstract][Full Text] [Related]
14. Albumin-Bilirubin (ALBI) Grade-Based Nomogram for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
Ho SY; Hsu CY; Liu PH; Lee RC; Ko CC; Huang YH; Su CW; Hou MC; Huo TI
Dig Dis Sci; 2021 May; 66(5):1730-1738. PubMed ID: 32548811
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Nomogram for Hepatitis B Virus-related Hepatocellular Carcinoma With Adjuvant Transarterial Chemoembolization After Radical Resection.
Huang J; Liu FC; Li L; Yuan SX; Yang Y; Jiang BG; Liu H; Pan ZY
Am J Clin Oncol; 2020 Jan; 43(1):20-27. PubMed ID: 31633514
[TBL] [Abstract][Full Text] [Related]
16. Nomogram for predicting post-therapy recurrence in BCLC A/B hepatocellular carcinoma with Child-Pugh B cirrhosis.
Qiao W; Sheng S; Xiong Y; Han M; Jin R; Hu C
Front Immunol; 2024; 15():1369988. PubMed ID: 38799452
[TBL] [Abstract][Full Text] [Related]
17. Contrast-Enhanced CT Imaging Features Combined with Clinical Factors to Predict the Efficacy and Prognosis for Transarterial Chemoembolization of Hepatocellular Carcinoma.
Sun Z; Shi Z; Xin Y; Zhao S; Jiang H; Li J; Li J; Jiang H
Acad Radiol; 2023 Sep; 30 Suppl 1():S81-S91. PubMed ID: 36803649
[TBL] [Abstract][Full Text] [Related]
18. Prognosis Nomogram for Hepatocellular Carcinoma Patients with Portal Vein Invasion Undergoing Transarterial Chemoembolization Plus Sorafenib Treatment: A Retrospective Multicentre Study.
Zhang L; Sun JH; Hou ZH; Zhong BY; Yang MJ; Zhou GH; Wang WS; Huang P; Zhang S; Li Z; Zhu XL; Yan ZP; Ni CF
Cardiovasc Intervent Radiol; 2021 Jan; 44(1):63-72. PubMed ID: 32965582
[TBL] [Abstract][Full Text] [Related]
19. Comparison of lipiodol infusion and drug-eluting beads transarterial chemoembolization of hepatocellular carcinoma in a real-life setting.
Karalli A; Teiler J; Haji M; Seth E; Brismar TB; Wahlin S; Axelsson R; Stål P
Scand J Gastroenterol; 2019 Jul; 54(7):905-912. PubMed ID: 31287338
[No Abstract] [Full Text] [Related]
20. CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study.
Wu B; Zhou J; Ling G; Zhu D; Long Q
World J Surg Oncol; 2018 Mar; 16(1):69. PubMed ID: 29587773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
